Literature DB >> 12723589

Pulmonary resection with chest wall removal and reconstruction for invasive pulmonary mucormycosis during antileukemia chemotherapy.

Katsuyuki Asai1, Kazuya Suzuki, Tsuyoshi Takahashi, Yasushi Ito, Teruhisa Kazui, Yusuke Kita.   

Abstract

A 54-year-old woman undergoing chemotherapy for acute myeloid leukemia developed invasive pulmonary mucormycosis in the right upper lobe at the neutropenic nadir. Amphotericin B therapy became ineffective after an abscess formed in the affected lung, and insufficient infection control compelled us to interrupt chemotherapy. The lesion was suspected of invading the anterior chest wall. After right upper lobectomy combined with the anterior chest wall resection, the chest wall defect was reconstructed using autologous free rib grafts. Successful control of the fungal infection by resection enabled us to restart chemotherapy with concomitant use of Amphotericin B. In selected cases of leukemia-associated pulmonary mucormycosis refractory to Amphotericin B therapy, aggressive surgical intervention may facilitate anti-leukemia chemotherapy and prolong survival.

Entities:  

Mesh:

Year:  2003        PMID: 12723589     DOI: 10.1007/s11748-003-0055-y

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  10 in total

1.  Mucormycosis in hematologic malignancies: an emerging fungal infection.

Authors:  A Nosari; P Oreste; M Montillo; G Carrafiello; M Draisci; G Muti; A Molteni; E Morra
Journal:  Haematologica       Date:  2000-10       Impact factor: 9.941

2.  Early and long-term results of prosthetic chest wall reconstruction.

Authors:  C Deschamps; B M Tirnaksiz; R Darbandi; V F Trastek; M S Allen; D L Miller; P G Arnold; P C Pairolero
Journal:  J Thorac Cardiovasc Surg       Date:  1999-03       Impact factor: 5.209

3.  Clinical spectrum of pulmonary mucormycosis.

Authors:  T D Bigby; M L Serota; L M Tierney; M A Matthay
Journal:  Chest       Date:  1986-03       Impact factor: 9.410

Review 4.  Pulmonary mucormycosis: the last 30 years.

Authors:  F Y Lee; S B Mossad; K A Adal
Journal:  Arch Intern Med       Date:  1999-06-28

5.  Chest wall reconstruction with autologas rib grafts in dogs and report of a clinic case.

Authors:  B Tunçözgür; L Elbeyli; A Güngör; F Işik; H Akay
Journal:  Eur J Cardiothorac Surg       Date:  1999-09       Impact factor: 4.191

6.  Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases.

Authors:  F Reichenberger; J Habicht; A Kaim; P Dalquen; F Bernet; R Schläpfer; P Stulz; A P Perruchoud; A Tichelli; A Gratwohl; M Tamm
Journal:  Am J Respir Crit Care Med       Date:  1998-09       Impact factor: 21.405

7.  Surgical aspects of resection for suspected invasive pulmonary fungal infection in neutropenic patients.

Authors:  J M Habicht; F Reichenberger; A Gratwohl; H R Zerkowski; M Tamm
Journal:  Ann Thorac Surg       Date:  1999-08       Impact factor: 4.330

Review 8.  Pulmonary mucormycosis: results of medical and surgical therapy.

Authors:  M Tedder; J A Spratt; M P Anstadt; S S Hegde; S D Tedder; J E Lowe
Journal:  Ann Thorac Surg       Date:  1994-04       Impact factor: 4.330

9.  Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resection.

Authors:  P Moreau; J R Zahar; N Milpied; O Baron; B Mahé; D Wu; P Germaud; P Despins; A Y Delajartre; J L Harousseau
Journal:  Cancer       Date:  1993-12-01       Impact factor: 6.860

10.  Pulmonary resection for invasive Aspergillus infections in immunocompromised patients.

Authors:  L A Robinson; E C Reed; T A Galbraith; A Alonso; A L Moulton; W H Fleming
Journal:  J Thorac Cardiovasc Surg       Date:  1995-06       Impact factor: 5.209

  10 in total
  8 in total

1.  Full-thickness chest wall reconstruction using autologous tissue grafts after resection of recurrent desmoid tumor.

Authors:  Katsuyuki Asai; Kazuya Suzuki; Hiroshi Shimota; Yasushi Ito; Kazutoshi Asano; Teruhisa Kazui
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-06

2.  Gastrointestinal mucormycosis: an evolving disease.

Authors:  Brad Spellberg
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-02

Review 3.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

4.  The rise of an opportunistic infection called "Invasive Zygomycosis".

Authors:  Abdelkarim Waness; Ghuzayel Al Dawsari; Hamdan Al Jahdali
Journal:  J Glob Infect Dis       Date:  2009-07

5.  Recent advances in the treatment of mucormycosis.

Authors:  Brad Spellberg; Ashraf S Ibrahim
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

Review 6.  Recent advances in the management of mucormycosis: from bench to bedside.

Authors:  Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis; John Edwards; Ashraf S Ibrahim
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

7.  Pulmonary Mucormycosis in a Patient with Chronic Rejection of Kidney Transplant: A Case Report.

Authors:  Mahshid Talebi-Taher; Seyedeh Nina Alavi Niakou; Seied Ali Javad-Mousavi; Mohammad Vaziri; Aida Iranpour; Maryam Dehghani
Journal:  Tanaffos       Date:  2015

8.  Rare complication of bronchoesophageal fistula due to pulmonary mucormycosis after induction chemotherapy for acute myeloid leukemia: a case report.

Authors:  Jun-Hyung Lee; Jin-Soo Hyun; Da-Yeong Kang; Hee-Jeong Lee; Sang-Gon Park
Journal:  J Med Case Rep       Date:  2016-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.